GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease
GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback